|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 03:37PM
|
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 03:57PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 11:22PM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 02:15PM
|
|
Re: Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 09:06PM
|
|
Re: ORI Debenture
|
3
|
Resverlogix Corp.
|
Oct 03, 2019 08:12PM
|
|
Re: Don's latest presentation - Pfizer's SGLT2 is Steglatro (Ertugliflozin)
|
3
|
Resverlogix Corp.
|
Sep 23, 2020 01:22PM
|
|
Closing in on 10 months
|
3
|
Zenith Epigenetics
|
Jun 18, 2017 07:05PM
|
|
Re: Back to the FDA
|
3
|
Resverlogix Corp.
|
Oct 03, 2019 08:32PM
|
|
Re: Congratulations to Imtesty on winning the Share Price Contest
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 04:32PM
|
|
Re: Cash burn and the cost of servicing the loan....
|
3
|
Resverlogix Corp.
|
Apr 17, 2018 02:00AM
|
|
Re: wondering if Dart & co...
|
3
|
Resverlogix Corp.
|
Jun 27, 2019 06:00PM
|
|
Re: Why is "Going it Alone" out of the question??
|
3
|
Resverlogix Corp.
|
Aug 14, 2020 06:48PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
3
|
Resverlogix Corp.
|
Sep 01, 2021 10:20PM
|
|
Re: Zenith trial partners
|
3
|
Zenith Epigenetics
|
Jan 30, 2023 03:27PM
|
|
Re: Can someone explain the Biogen situation to me....
|
3
|
Resverlogix Corp.
|
Oct 28, 2019 01:46PM
|
|
Re: Showcase Presentations
|
3
|
Resverlogix Corp.
|
Jan 16, 2017 08:32PM
|
|
Re: Morocco
|
3
|
Resverlogix Corp.
|
Sep 12, 2023 05:13PM
|
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
3
|
Resverlogix Corp.
|
Apr 14, 2019 12:29PM
|
|
Re: What's the deal with Zenith?
|
3
|
Zenith Epigenetics
|
Jun 23, 2023 01:54AM
|
